Literature DB >> 17011556

Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells.

Francisco Valladares1, Ignacio Frías, Delia Báez, Candelaria García, Francisco J López, James D Fraser, Yurena Rodríguez, Ricardo Reyes, Lucio Díaz-Flores, Aixa R Bello.   

Abstract

OBJECTIVE: Cellular and subcellular localization of estrogen receptor alpha (ERalpha) and estrogen receptor beta (ERbeta) in uterine leiomyomas.
DESIGN: Retrospective study.
SETTING: University of La Laguna (ULL) and Canary University Hospital (HUC). PATIENT(S): Premenopausal and postmenopausal women with uterine leiomyomas. INTERVENTION(S): Hysterectomy and myomectomy. RESULT(S): Estrogen receptor alpha was only present in smooth muscle cells with variation in the subcellular location in different leiomyomas. Estrogen receptor beta was widely distributed in smooth muscle, endothelial, and connective tissue cells with nuclear location in all cases studied; variations were only found in the muscle cells for this receptor. CONCLUSION(S): Estrogens operate in leiomyoma smooth muscle cells through different receptors, alpha and beta. However they only act through the ERbeta in endothelial and connective cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011556     DOI: 10.1016/j.fertnstert.2006.05.047

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

2.  Association of estrogen and progesterone receptor gene polymorphisms and their respective hormones in uterine leiomyomas.

Authors:  M Veronica; Altaf Ali; A Venkateshwari; D Mamata; Pratibha Nallari
Journal:  Tumour Biol       Date:  2015-12-29

Review 3.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

4.  Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.

Authors:  Bruce R Carr; Elizabeth A Stewart; David F Archer; Ayman Al-Hendy; Linda Bradley; Nelson B Watts; Michael P Diamond; Jingjing Gao; Charlotte D Owens; Kristof Chwalisz; W Rachel Duan; Ahmed M Soliman; Matthew B Dufek; James A Simon
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

5.  Uterine Myomas and Sarcomas - Clinical and Ultrasound Characteristics and Differential Diagnosis Using Pulsed and Color Doppler Techniques.

Authors:  Kamila Wojtowicz; Tomasz Góra; Paweł Guzik; Magdalena Harpula; Paweł Chechliński; Ewelina Wolak; Aleksandra Stryjkowska-Góra
Journal:  J Ultrason       Date:  2022-04-27

6.  Inverse association between estrogen receptor-α DNA methylation and breast composition in adolescent Chilean girls.

Authors:  Alexandra M Binder; Leah T Stiemsma; Kristen Keller; Sanne D van Otterdijk; Verónica Mericq; Ana Pereira; José L Santos; John Shepherd; Karin B Michels
Journal:  Clin Epigenetics       Date:  2018-10-04       Impact factor: 6.551

7.  LncRNA SRA1 may play a role in the uterine leiomyoma tumor growth regarding the MED12 mutation pattern.

Authors:  Mojdeh Akbari; Fakhrolmolouk Yassaee; Mona Aminbeidokhti; Atieh Abedin-Do; Reza Mirfakhraie
Journal:  Int J Womens Health       Date:  2019-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.